Better Science, Better Health: New Healthcare Models Event Report We are riding a wave of unprecedented medical innovation, but currently living with regulatory, reimbursement and healthcare systems that are failing to deliver the benefits to patients. The will is there, in the shape of a number of research projects, pilots and other [...]
Better Science, Better Health: New Healthcare Models Pictures Conference 27th Oct 2015 Caucus Room Dinner 27th Oct 2015 Folger Shakespeare Library Conference 28th Oct 2015 Capitol Visitor Center Videos 27th October: Opening Keynote Session: International Collaboration for Better Healthcare 27th October: Fostering Collaboration [...]
Better Science, Better Health: New Healthcare Models Downloads Click on the names to download the presentations. Opening Keynote Session: International Collaboration for Better Healthcare Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency Lynn D. Hudson, Chief Science Officer, Critical Path Institute Pierre Meulien, Executive Director, Innovative Medicines Initiative Fostering Collaboration [...]
Michael C. Burgess M.D. US Congressman After spending nearly three decades practicing medicine in North Texas I have served the constituents of the 26th District since 2003 in the United States House of Representatives. I currently serve on the prestigious House Energy and Commerce Committee where I serve as Chairman of the House Energy and [...]
Ryan Hohman Managing Director, Policy & Public Affairs, Friends of Cancer Research Ryan Hohman, JD, serves as Managing Director, Policy & Public Affairs at Friends of Cancer Research (Friends), a think tank and advocacy organization based in Washington, D.C. Friends is our country’s leading voice in advocating for policies and proposing and promoting real solutions [...]
Carol Linden Director Office of Regulatory Science and Innovation, FDA Dr. Linden currently serves as the Director, Office of Regulatory Science and Innovation in the Office of the Chief Scientist, Office of the Commissioner, U.S. Food and Drug Administration. There she oversees a broad array of both intramural and extramural programs focused on bringing understanding [...]
Adam Heathfield Senior Director Global Health and Value Innovation Center, Pfizer, UK Adam has worked for Pfizer for nine years. His current role is Senior Director in Pfizer’s Global Health and Value Innovation Center. Previously, Adam has worked in Pfizer’s international policy division and led Pfizer’s work on science policy in Europe for several years. [...]
Better Science, Better Health: New Healthcare Models Join the conversation on Twitter #BSBH15 The Venues 1. Hotel George 15, E street, NW, Washington, DC 20001 2. Cannon House Office Building, Cannon Caucas Room 27 Independence Ave SE, Washington, DC 20003 Please use the visitor entrance; [...]
Jocelyn Ulrich, MPH Senior Director, Scientific and Regulatory Affairs, PhRMA Jocelyn B. Ulrich, MPH, RAC is Senior Director, Scientific and Regulatory Affairs at PhRMA, where she supports PhRMA’s policy advocacy strategies on clinical trials and innovative biologics and biosimilars. Prior to joining PhRMA, Jocelyn held positions of increasing responsibility at Pfizer and Human Genome Sciences [...]
Dr. Lynn D. Hudson Chief Science Officer for the Critical Path Institute (C-Path) and Executive Director of the Multiple Sclerosis Outcome Assessments Consortium Dr. Lynn D. Hudson serves as the Chief Science Officer for the Critical Path Institute (C-Path) and Executive Director of the Multiple Sclerosis Outcome Assessments Consortium. She started at C-Path by overseeing [...]